This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
“EST73502” (ESTEVE oral dual mu-opioid receptor agonist, sigma-1 receptor antagonist clinical candidate)
molecule
2 years ago ●
1 min read
CG428 (Cullgen CRBN-based TRK kinase fusion protein degrader)
molecule
2 years ago ●
1 min read
“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)
molecule
2 years ago ●
1 min read
FGF401 (roblitinib) is a highly selective, reversible-covalent inhibitor of the kinase FGFR4, a receptor that can drive progression of certain cancers.…
molecule
2 years ago ●
1 min read
TNO155 is an allosteric inhibitor of the SHP2 phosphatase, which has been a hot target in oncology recently due to its…
molecule
2 years ago ●
1 min read
BMS-986143 is a potent, reversible inhibitor of the Bruton’s tyrosine kinase (BTK), which has been successfully targeted by a number of…
molecule
2 years ago ●
1 min read
Load More
